Literature DB >> 12507886

Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression.

Balveen Kaur1, Daniel J Brat, Cathárine C Calkins, Erwin G Van Meir.   

Abstract

Brain angiogenesis inhibitors (BAI) are putative transmembrane proteins containing an extracellular domain with thrombospondin type-1 repeats which can exhibit anti-angiogenic activity. BAI1 mRNA is expressed mainly in the brain, while BAI2 and BAI3 mRNAs are more widely expressed. We hypothesized that the BAI family might have anti-tumoral properties and studied the expression of BAI1 protein in normal human brain and in glioblastoma multiforme. We generated an anti-BAI1 antibody and showed that BAI1 was widely expressed in normal brain but was absent in 28 glioma cell lines and in the majority of human glioblastoma investigated. BAI1 expression did not correlate with TP53 status and we did not confirm previous findings that p53 regulates BAI1 mRNA expression in glioma cells. The finding that expression of BAI proteins may be lost during tumor formation is of special interest as restoration of their function in tumors may be of therapeutic benefit.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507886      PMCID: PMC1851137          DOI: 10.1016/S0002-9440(10)63794-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Glioblastoma multiforme: the terminator.

Authors:  E C Holland
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Restoration of endogenous wild-type p53 activity in a glioblastoma cell line with intrinsic temperature-sensitive p53 induces growth arrest but not apoptosis.

Authors:  J Ikeda; M Tada; N Ishii; H Saya; K Tsuchiya; K Okaichi; K Mishima; Y Sawamura; G Fulci; T J Liu; E G Van Meir
Journal:  Int J Cancer       Date:  2001-10-01       Impact factor: 7.396

Review 3.  Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research.

Authors:  D J Brat; E G Van Meir
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

4.  Expression of angiostatic factors in colorectal cancer.

Authors:  Y Yoshida; Y Oshika; Y Fukushima; T Tokunaga; H Hatanaka; H Kijima; H Yamazaki; Y Ueyama; N Tamaoki; S Miura; M Nakamura
Journal:  Int J Oncol       Date:  1999-12       Impact factor: 5.650

5.  p53 and c-Jun functionally synergize in the regulation of the DNA repair gene hMSH2 in response to UV.

Authors:  S J Scherer; S M Maier; M Seifert; R G Hanselmann; K D Zang; H K Muller-Hermelink; P Angel; C Welter; M Schartl
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

6.  Identification of the putative brain tumor antigen BF7/GE2 as the (de)toxifying enzyme microsomal epoxide hydrolase.

Authors:  R Kessler; M F Hamou; M Albertoni; N de Tribolet; M Arand; E G Van Meir
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

Review 7.  Thrombospondins and tumor angiogenesis.

Authors:  F de Fraipont; A C Nicholson; J J Feige; E G Van Meir
Journal:  Trends Mol Med       Date:  2001-09       Impact factor: 11.951

8.  Comparative study of angiostatic and anti-invasive gene expressions as prognostic factors in gastric cancer.

Authors:  J H Lee; J T Koh; B A Shin; K Y Ahn; J H Roh; Y J Kim; K K Kim
Journal:  Int J Oncol       Date:  2001-02       Impact factor: 5.650

Review 9.  Evolution of functions within the p53/p63/p73 family.

Authors:  V De Laurenzi; G Melino
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

10.  Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells.

Authors:  M Tenan; G Fulci; M Albertoni; A C Diserens; M F Hamou; M El Atifi-Borel; J J Feige; M S Pepper; E G Van Meir
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

View more
  47 in total

1.  Defective p53 antiangiogenic signaling in glioblastoma.

Authors:  Benjamin Berger; David Capper; Dieter Lemke; Philipp-Niclas Pfenning; Michael Platten; Michael Weller; Andreas von Deimling; Wolfgang Wick; Markus Weiler
Journal:  Neuro Oncol       Date:  2010-05-26       Impact factor: 12.300

Review 2.  Adhesion G Protein-Coupled Receptors: From In Vitro Pharmacology to In Vivo Mechanisms.

Authors:  Kelly R Monk; Jörg Hamann; Tobias Langenhan; Saskia Nijmeijer; Torsten Schöneberg; Ines Liebscher
Journal:  Mol Pharmacol       Date:  2015-05-08       Impact factor: 4.436

3.  N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.

Authors:  Satoru Osuka; Dan Zhu; Zhaobin Zhang; Chaoxi Li; Christian T Stackhouse; Oltea Sampetrean; Jeffrey J Olson; G Yancey Gillespie; Hideyuki Saya; Christopher D Willey; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 4.  Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.

Authors:  Patrick R Lawler; Jack Lawler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

Review 5.  Biology of angiogenesis and invasion in glioma.

Authors:  Matthew C Tate; Manish K Aghi
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

6.  The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins.

Authors:  Marc F Bolliger; David C Martinelli; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

7.  Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1.

Authors:  Dan Zhu; Stephen B Hunter; Paula M Vertino; Erwin G Van Meir
Journal:  Cancer Res       Date:  2011-07-01       Impact factor: 12.701

8.  Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.

Authors:  Balveen Kaur; Sarah M Cork; Eric M Sandberg; Narra S Devi; Zhaobin Zhang; Philip A Klenotic; Maria Febbraio; Hyunsuk Shim; Hui Mao; Carol Tucker-Burden; Roy L Silverstein; Daniel J Brat; Jeffrey J Olson; Erwin G Van Meir
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

Review 9.  Anti-angiogenic gene therapy in the treatment of malignant gliomas.

Authors:  NaTosha N Gatson; E Antonio Chiocca; Balveen Kaur
Journal:  Neurosci Lett       Date:  2012-08-10       Impact factor: 3.046

10.  Significance of p53 and CD31 in astrogliomas.

Authors:  Abdul-Zaher M Khattab; Magdy I Ahmed; Mohamed A Fouad; Waleed A Essa
Journal:  Med Oncol       Date:  2008-09-20       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.